CVR: 36699051
Secondary names: Pharmamentum ApS, Pharmanovia Denmark ApS
Previous names: Pharmamentum ApS
DKK 71,428,252
Revenue
Net result: DKK 47,843
Atnahs Pharma UK Limited
CVR · view ownership and management
Director role ended: Neeshe Bhikhubhai Williams
CVR · 09/06/2026
View the full event history
Atnahs Pharma Denmark ApS is a Danish company of the type Anpartsselskab based in København S, founded in 2015. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company was previously named Pharmamentum ApS. The management consists of Christoph Michael Habereder. The company is owned by Atnahs Pharma UK Limited. In 2025, the company reported revenue of DKK 71,428,252 and a net result of DKK 47,843 compared with EUR 20,450 the year before. Equity in the 2025 report amounted to DKK 2,081,649.
Source: annual report 2025, Danish Business Authority
Atnahs Pharma Denmark ApS has experienced significant fluctuations in its financial performance over recent years. In 2025, the company reported a revenue of 71.4 million DKK with a modest profit of 47,843 DKK, indicating a recovery from a challenging 2023 where it faced a gross loss of 19.4 million DKK despite a revenue of 517.2 million DKK. The equity position has improved to 2.1 million DKK in 2025 from a negative equity of -3.5 million DKK in 2021, reflecting a positive trend. However, the gross profit margins remain thin, raising concerns about sustainability. Positioned within the pharmaceutical wholesale sector, Atnahs Pharma's size and recent revenue trends suggest it is navigating a volatile market landscape.
AI-generated summary · Generated 20/08/2026
Selskabets formål er at drive handelsvirksomhed med farmaceutiske produkter, herunder udvikling, salg, distribution og markedsføring af farmaceutiske produkter og dermed beslægtet virksomhed.
Source: annual reports filed with the Danish Business Authority.
| Period | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/04/2024 – 31/03/2025 | 71.4 mio. | 48 t. | 51.2 mio. | 2.1 mio. | 0 | |
| 202401/04/2023 – 31/03/2024 | 91.3 mio. EUR | 20 t. EUR | 67 mio. EUR | 2 mio. EUR | - | |
| 202301/04/2022 – 31/03/2023 | 517.2 mio. | 14.7 mio. | 407.3 mio. | 14.9 mio. | - | |
| 202201/04/2021 – 31/03/2022 | - | 3.6 mio. | 202.9 mio. | 142 t. | - | |
| 202101/04/2020 – 31/03/2021 | - | 275 t. | 127.9 mio. | -3.5 mio. | - | |
| 202001/04/2019 – 31/03/2020 | - | -1.4 mio. | 3.9 mio. | -3.8 mio. | - | |
| 201901/04/2018 – 31/03/2019 | - | -1.1 mio. | 1.2 mio. | -2.4 mio. | - | |
| 201801/04/2017 – 31/03/2018 | - | -1.9 mio. | 7.2 mio. | -1.3 mio. | - |
Compared to 407 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringAtnahs Pharma Denmark ApS was founded on 27 March 2015.
Atnahs Pharma Denmark ApS is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler (industry code 464610).
Atnahs Pharma Denmark ApS is owned by Atnahs Pharma UK Limited.
In 2025, Atnahs Pharma Denmark ApS reported revenue of DKK 71,428,252.
The management of Atnahs Pharma Denmark ApS consists of Christoph Michael Habereder.
Atnahs Pharma Denmark ApS is located at c/o Pharmanovia A/S, Ørestads Boulevard 108 5. tv, 2300 København S.
Claim this page to add your logo and social links. Free to get started.
As of June 9, 2026, Neeshe Bhikhubhai Williams has left the board of directors of Atnahs Pharma Denmark ApS.
As of June 9, 2026, Christoph Michael Habereder is registered as director of Atnahs Pharma Denmark ApS.
As of June 9, 2026, Neeshe Bhikhubhai Williams has stepped down as director of Atnahs Pharma Denmark ApS.
As of March 24, 2026, Mohammad Muqtadir Samy has joined the board of directors of Atnahs Pharma Denmark ApS.
As of March 24, 2026, Amit Vijaykumar Patel has left the board of directors of Atnahs Pharma Denmark ApS.
As of March 23, 2026, Mohammad Muqtadir Samy has left the board of directors of Atnahs Pharma Denmark ApS.
As of February 17, 2026, Twan Johannes Anna Nouwen has joined the board of directors of Atnahs Pharma Denmark ApS.
As of February 17, 2026, Mohammad Muqtadir Samy has joined the board of directors of Atnahs Pharma Denmark ApS.
As of February 17, 2026, Christoph Michael Habereder has joined the board of directors of Atnahs Pharma Denmark ApS.
As of February 17, 2026, Santsagar Patel has left the board of directors of Atnahs Pharma Denmark ApS.
As of November 26, 2025, CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB has been appointed auditor of Atnahs Pharma Denmark ApS.
As of November 26, 2025, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Atnahs Pharma Denmark ApS.
Atnahs Pharma Denmark ApS has published its annual report for 2025. Revenue came to DKK 71,428,252, and the net result was DKK 47,843.
As of September 30, 2025, James Sang Bum Lee has left the board of directors of Atnahs Pharma Denmark ApS.
As of September 30, 2025, Zubair Javeed has left the board of directors of Atnahs Pharma Denmark ApS.
As of September 30, 2025, Neeshe Bhikhubhai Williams is registered as director of Atnahs Pharma Denmark ApS.
As of September 30, 2025, James Sang Bum Lee has stepped down as director of Atnahs Pharma Denmark ApS.
As of August 25, 2025, DELOITTE STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Atnahs Pharma Denmark ApS.
As of August 19, 2025, KPMG P/S has stepped down as auditor of Atnahs Pharma Denmark ApS.
As of May 1, 2025, Santsagar Patel has joined the board of directors of Atnahs Pharma Denmark ApS.
As of May 1, 2025, Zubair Javeed has joined the board of directors of Atnahs Pharma Denmark ApS.
As of May 1, 2025, James Charles Burt has left the board of directors of Atnahs Pharma Denmark ApS.
Atnahs Pharma Denmark ApS has published its annual report for 2024. Revenue came to DKK 91,292,078, and the net result was DKK 20,450.
Atnahs Pharma Denmark ApS has published its annual report for 2023. Revenue came to DKK 517,225,669, and the net result was DKK 14,720,135.
As of October 6, 2023, Jesper Wilhelm Voss has left the board of directors of Atnahs Pharma Denmark ApS.
As of October 6, 2023, James Sang Bum Lee is registered as director of Atnahs Pharma Denmark ApS.
As of October 6, 2023, Amit Vijaykumar Patel has stepped down as director of Atnahs Pharma Denmark ApS.
As of May 24, 2023, James Sang Bum Lee has joined the board of directors of Atnahs Pharma Denmark ApS.
As of May 24, 2023, Felipe Andres Florez Arango has left the board of directors of Atnahs Pharma Denmark ApS.
Atnahs Pharma Denmark ApS has published its annual report for 2022. Gross profit came to DKK 9,761,758, and the net result was DKK 3,647,068.
As of March 29, 2022, Rishi Bhikhu has left the board of directors of Atnahs Pharma Denmark ApS.
As of December 17, 2021, James Charles Burt has joined the board of directors of Atnahs Pharma Denmark ApS.
As of December 17, 2021, Alastair Thomas Badgett Hay has left the board of directors of Atnahs Pharma Denmark ApS.
Atnahs Pharma Denmark ApS has published its annual report for 2021. Gross profit came to DKK 5,092,802, and the net result was DKK 275,303.
As of June 16, 2021, Felipe Andres Florez Arango has joined the board of directors of Atnahs Pharma Denmark ApS.
As of February 10, 2021, Jesper Wilhelm Voss has joined the board of directors of Atnahs Pharma Denmark ApS.
As of February 10, 2021, Svend Aage Johansen has left the board of directors of Atnahs Pharma Denmark ApS.
Atnahs Pharma Denmark ApS has published its annual report for 2020. Gross profit came to DKK -1,258,513, and the net result was DKK -1,418,130.
As of February 24, 2020, Anthony Charles Playle has left the board of directors of Atnahs Pharma Denmark ApS.
Atnahs Pharma Denmark ApS has published its annual report for 2019. Gross profit came to DKK 778,878, and the net result was DKK -1,052,467.
As of August 7, 2019, Svend Aage Johansen has joined the board of directors of Atnahs Pharma Denmark ApS.
As of August 7, 2019, Neeshe Bhikhubhai Williams has joined the board of directors of Atnahs Pharma Denmark ApS.
As of August 7, 2019, Rishi Bhikhu has joined the board of directors of Atnahs Pharma Denmark ApS.
As of August 7, 2019, Alastair Thomas Badgett Hay has joined the board of directors of Atnahs Pharma Denmark ApS.
As of August 7, 2019, Dipen Vijaykumar Patel has left the board of directors of Atnahs Pharma Denmark ApS.
As of August 7, 2019, Mark John Cotterill has left the board of directors of Atnahs Pharma Denmark ApS.
As of February 28, 2019, Mark John Cotterill has joined the board of directors of Atnahs Pharma Denmark ApS.
As of February 28, 2019, Svend Aage Johansen has left the board of directors of Atnahs Pharma Denmark ApS.
As of February 28, 2019, Amit Vijaykumar Patel is registered as director of Atnahs Pharma Denmark ApS.
As of February 28, 2019, Svend Aage Johansen has stepped down as director of Atnahs Pharma Denmark ApS.
On January 15, 2019, the company changed its name from Pharmamentum ApS to Atnahs Pharma Denmark ApS.
Atnahs Pharma Denmark ApS has published its annual report for 2018. Gross profit came to DKK -1,427,823, and the net result was DKK -1,858,350.
As of February 28, 2018, is registered as an owner of Atnahs Pharma Denmark ApS with an ownership share of 100%.
Atnahs Pharma Denmark ApS has published its interim report for the period January 1, 2016 – March 31, 2017.
Atnahs Pharma Denmark ApS has published its interim report for the period March 27, 2015 – December 31, 2015.
As of April 20, 2016, KPMG P/S has been appointed auditor of Atnahs Pharma Denmark ApS.
As of March 31, 2016, Svend Aage Johansen has joined the board of directors of Atnahs Pharma Denmark ApS.
As of March 31, 2016, Amit Vijaykumar Patel has joined the board of directors of Atnahs Pharma Denmark ApS.
As of March 31, 2016, Dipen Vijaykumar Patel has joined the board of directors of Atnahs Pharma Denmark ApS.
As of March 31, 2016, Anthony Charles Playle has joined the board of directors of Atnahs Pharma Denmark ApS.
As of March 31, 2016, Svend Aage Johansen is registered as director of Atnahs Pharma Denmark ApS.
As of March 31, 2016, Lisbet Johansen has stepped down as director of Atnahs Pharma Denmark ApS.
As of March 27, 2015, Lisbet Johansen is registered as director of Atnahs Pharma Denmark ApS.
Atnahs Pharma Denmark ApS was founded on March 27, 2015.
Companies in the same industry and area
CVR 41722460
CVR 39371049
CVR 39503778
CVR 40873309
CVR 31774284
